Inventor · disambiguated record
Felix Feng
Also filed as: FENG FELIX · FENG FELIX Y · FENG FELIX YI-CHUNG
4 granted patents·12 pending applications·3 citations·filing 2014–2024
59Inventor score
Top patents by PatentIndex Score
16 records- 0182US11414708B2Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapyDECIPHER BIOSCIENCES INC·Filed 2017·Granted Aug 16, 2022·3 cites·9 claims
- 0268US2024360517A1Subtyping prostate cancer to predict response to hormone therapyVERACYTE SD INC·Filed 2024·Application pending·0 cites
- 0362US2023151429A1Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapyVERACYTE SD INC·Filed 2022·Application pending·0 cites
- 0460US2025104827A1Systems and methods for determining cancer therapy via deep learningARTERA INC·Filed 2024·Application pending·0 cites
- 0560US2024395407A1Methods and systems for digital pathology assessment of cancer via deep learningARTERA INC·Filed 2024·Application pending·0 cites
- 0660US2025054624A1Methods and systems for digital pathology assessment of cancer via deep learningARTERA INC·Filed 2024·Application pending·0 cites
- 0753US11873532B2Subtyping prostate cancer to predict response to hormone therapyVERACYTE SD INC·Filed 2018·Granted Jan 16, 2024·0 cites·10 claims
- 0851US2022091102A1Screening for Inhibitors of Prostaglandin E Synthase 3 Useful for Treatment of Prostate CancerUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 0950US2025005745A1Systems and methods for determining cancer therapy via deep learningARTERA INC·Filed 2024·Application pending·0 cites
- 1045US12497660B2Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapyDECIPHER BIOSCIENCES INC·Filed 2018·Granted Dec 16, 2025·0 cites·19 claims
- 1145US10889864B2Non-coding RNAS and uses thereofUNIV MICHIGAN REGENTS·Filed 2015·Granted Jan 12, 2021·0 cites·12 claims
- 1240US2015232931A1Compositions and methods for the analysis of radiosensitivityUNIV MICHIGAN·Filed 2014·Application pending·0 cites
- 1339US2022033912A1Transcriptomic profiling for prognosis of breast cancer to identify subjects who may be spared adjuvant systemic therapyPFS GENOMICS INC·Filed 2019·Application pending·0 cites
- 1438US2018369241A1Treatment of cancer with dnapk inhibitorsCELGENE CORP·Filed 2016·Application pending·0 cites
- 1538US2024145032A1Methods and genomic classifiers for prognosis of breast cancer and identifying subjects not likely to benefit from radiotherapyPFS GENOMICS INC·Filed 2022·Application pending·0 cites
- 1630US2022002815A1Methods and genomic classifiers for prognosis of breast cancer and predicting benefit from adjuvant radiotherapyPFS GENOMICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Felix Feng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →